Rituximab-alone in GPA and MPA
3 september, 2025
Real world experience A recently published study in Clinical and Experimental Rheumatology offers new real-world data from the University of
What’s going on in the world of vasculitis…?
Real world experience A recently published study in Clinical and Experimental Rheumatology offers new real-world data from the University of
The National Institute for Health and Care Excellence (NICE) has officially recommended benralizumab (Fasenra) as a new treatment option for adults with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA).
The two-year MANDARA study found benralizumab and mepolizumab equally effective for eosinophilic granulomatosis with polyangiitis (EGPA). About two-thirds of patients
Today, May 15th, is International Vasculitis Day. The entire month of May is dedicated to raising awareness about vasculitis, culminating
Challenges in the Diagnosis and Treatment of Systemic Vasculitis SOCHIRE Celebrates 75th Anniversary Chile may be far away for many
Die SHG Mainz (Sebst Hilfe Grupppe) feiert am 14. Dezember ihr 10-jähriges Bestehen! Herzlichen Glückwunsch an Hermann Götz! Gemeinsam mit